Literature DB >> 33666199

Antiviral effect of amiodarone and its possible role in COVID-19: An appraisal.

Snehal Lonare1, Mythili Hazarika2, Chandra Kr Das3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33666199      PMCID： PMC8092184          DOI： 10.4103/ijp.IJP_714_20

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN： 0253-7613            Impact factor:   1.200


× No keyword cloud information.
  9 in total

1.  Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.

Authors:  Yuan-Lung Cheng; Keng-Hsueh Lan; Wei-Ping Lee; Szu-Han Tseng; Li-Rong Hung; Han-Chieh Lin; Fa-Yauh Lee; Shou-Dong Lee; Keng-Hsin Lan
Journal:  Clin Sci (Lond)       Date:  2013-11       Impact factor: 6.124

Review 2.  Angiotensin Converting Enzyme 2: A Double-Edged Sword.

Authors:  Kaiming Wang; Mahmoud Gheblawi; Gavin Y Oudit
Journal:  Circulation       Date:  2020-03-26       Impact factor: 29.690

3.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

4.  COVID-19 and the Heart.

Authors:  Akbarshakh Akhmerov; Eduardo Marbán
Journal:  Circ Res       Date:  2020-04-07       Impact factor: 17.367

5.  Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration.

Authors:  Erika Hrudikova Vyskocilova; Milan Grundmann; Jana Duricova; Ivana Kacirova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2017-03-31       Impact factor: 1.245

Review 6.  [Clinical aspects of treatment with amiodarone].

Authors:  W Haverkamp; C Israel; A Parwani
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-09

7.  Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.

Authors:  Konrad Stadler; Huy Riem Ha; Vincenzo Ciminale; Carlo Spirli; Giulietta Saletti; Marco Schiavon; Daniela Bruttomesso; Laurent Bigler; Ferenc Follath; Andrea Pettenazzo; Aldo Baritussio
Journal:  Am J Respir Cell Mol Biol       Date:  2008-02-28       Impact factor: 6.914

8.  In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus.

Authors:  Julie Dyall; Joshua C Johnson; Brit J Hart; Elena Postnikova; Yu Cong; Huanying Zhou; Dawn M Gerhardt; Julia Michelotti; Anna N Honko; Steven Kern; Lisa Evans DeWald; Kathleen G O'Loughlin; Carol E Green; Jon C Mirsalis; Richard S Bennett; Gene G Olinger; Peter B Jahrling; Lisa E Hensley
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

9.  Safety and Efficacy of Amiodarone in a Patient With COVID-19.

Authors:  Nadia Castaldo; Alberto Aimo; Vincenzo Castiglione; Cristiano Padalino; Michele Emdin; Carlo Tascini
Journal:  JACC Case Rep       Date:  2020-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.